Longitude Capital Partners Iv, Llc - Net Worth and Insider Trading
Longitude Capital Partners Iv, Llc Net Worth
The estimated net worth of Longitude Capital Partners Iv, Llc is at least $246 Million dollars as of 2024-05-12. Longitude Capital Partners Iv, Llc is the 10% Owner of Vera Therapeutics Inc and owns about 5,144,212 shares of Vera Therapeutics Inc (VERA) stock worth over $213 Million. Longitude Capital Partners Iv, Llc is also the 10% Owner of Lexeo Therapeutics Inc and owns about 2,567,100 shares of Lexeo Therapeutics Inc (LXEO) stock worth over $34 Million. Details can be seen in Longitude Capital Partners Iv, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Longitude Capital Partners Iv, Llc has not made any transactions after 2023-11-07 and currently still holds the listed stock(s).
Transaction Summary of Longitude Capital Partners Iv, Llc
Longitude Capital Partners Iv, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Longitude Capital Partners Iv, Llc owns 3 companies in total, including Eargo Inc (EAR) , Vera Therapeutics Inc (VERA) , and Lexeo Therapeutics Inc (LXEO) .
Insider Ownership Summary of Longitude Capital Partners Iv, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
| VERA | Vera Therapeutics Inc | 2023-02-06 | 10 percent owner |
| LXEO | Lexeo Therapeutics Inc | 2023-11-07 | 10 percent owner |
Longitude Capital Partners Iv, Llc Latest Holdings Summary
Longitude Capital Partners Iv, Llc currently owns a total of 2 stocks. Among these stocks, Longitude Capital Partners Iv, Llc owns 5,144,212 shares of Vera Therapeutics Inc (VERA) as of February 6, 2023, with a value of $213 Million and a weighting of 86.3%. Longitude Capital Partners Iv, Llc also owns 2,567,100 shares of Lexeo Therapeutics Inc (LXEO) as of November 7, 2023, with a value of $34 Million and a weighting of 13.7%.
Latest Holdings of Longitude Capital Partners Iv, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERA | Vera Therapeutics Inc | 2023-02-06 | 5,144,212 | 41.32 | 212,558,840 |
| LXEO | Lexeo Therapeutics Inc | 2023-11-07 | 2,567,100 | 13.14 | 33,731,694 |
Holding Weightings of Longitude Capital Partners Iv, Llc
Longitude Capital Partners Iv, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Longitude Capital Partners Iv, Llc has made a total of 2 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vera Therapeutics Inc is the acquisition of 1,714,285 shares on February 6, 2023, which cost Longitude Capital Partners Iv, Llc around $12 Million.
According to the SEC Form 4 filings, Longitude Capital Partners Iv, Llc has made a total of 1 transactions in Lexeo Therapeutics Inc (LXEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexeo Therapeutics Inc is the acquisition of 454,545 shares on November 7, 2023, which cost Longitude Capital Partners Iv, Llc around $5 Million.
Insider Trading History of Longitude Capital Partners Iv, Llc
- 1
Longitude Capital Partners Iv, Llc Trading Performance
GuruFocus tracks the stock performance after each of Longitude Capital Partners Iv, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longitude Capital Partners Iv, Llc is 21.51%. GuruFocus also compares Longitude Capital Partners Iv, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Longitude Capital Partners Iv, Llc within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Longitude Capital Partners Iv, Llc's insider trading performs compared to the benchmark.
Performance of Longitude Capital Partners Iv, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.01 | | | | | |
| Relative Return to S&P 500(%) | 26.75 | | | | | |
Longitude Capital Partners Iv, Llc Ownership Network
Longitude Capital Partners Iv, Llc Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Longitude Capital Partners Iv, Llc is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Longitude Capital Partners Iv, Llc made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Longitude Capital Partners Iv, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Longitude Capital Partners Iv, Llc. You might contact Longitude Capital Partners Iv, Llc via mailing address: 2740 Sand Hill Road, 2nd Floor, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
